Modifications produced by selective inhibitors of cyclooxygenase and ultra low dose aspirin on platelet activity in portal hypertension

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 38

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

293

HTML

1577

Figures (1-4)

245

Tables (1-1)

172

Sum=2287

Oct 14, 2007 (publication date) through Nov 5, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Oct 14, 2007; 13(38): 5065-5070
Published online Oct 14, 2007. doi: 10.3748/wjg.v13.i38.5065

Table 1 Experimental groups

ULDA: Ultra low dose aspirin; CMC: Carboxymethylcellulose; ShP: Sham-placebo; PHP: Portal hypertension-placebo; PHPAs: Portal hypertension-ULDA.

Citation: Eizayaga FX, Aguejouf O, Desplat V, Belon P, Doutremepuich C. Modifications produced by selective inhibitors of cyclooxygenase and ultra low dose aspirin on platelet activity in portal hypertension. World J Gastroenterol 2007; 13(38): 5065-5070
URL: https://www.wjgnet.com/1007-9327/full/v13/i38/5065.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i38.5065